Indivior PLC (INDV)
USD 11.98
(3.72%)
USD 11.98
(3.72%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 281.6 Million USD | 1.11% |
| 2022 | 278.49 Million USD | -2.43% |
| 2021 | 285.44 Million USD | 0.15% |
| 2020 | 284.99 Million USD | -2.73% |
| 2019 | 293 Million USD | 21.58% |
| 2018 | 240.99 Million USD | -50.0% |
| 2017 | 481.99 Million USD | -9.91% |
| 2016 | 534.99 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 238 Million USD | 1.05% |
| 2024 Q2 | 281.04 Million USD | 0.81% |
| 2024 Q1 | 278.79 Million USD | -1.0% |
| 2023 FY | 281.6 Million USD | 1.11% |
| 2023 Q4 | 281.6 Million USD | 1.73% |
| 2023 Q3 | 276.8 Million USD | -1.33% |
| 2023 Q2 | 280.54 Million USD | 0.81% |
| 2023 Q1 | 278.28 Million USD | -0.07% |
| 2022 Q1 | 281.28 Million USD | -1.46% |
| 2022 Q2 | 280.61 Million USD | -0.24% |
| 2022 Q3 | 275.92 Million USD | -1.67% |
| 2022 Q4 | 278.49 Million USD | 0.93% |
| 2021 Q4 | 285.44 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 540.94 Million USD | 47.943% |
| Theratechnologies Inc. | 58.96 Million USD | -377.55% |
| Safety Shot Inc | 1.54 Million USD | -18079.893% |
| Cosmos Health Inc. | 12.42 Million USD | -2166.604% |
| Cronos Group Inc. | 2.53 Million USD | -10986.956% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 60.645% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | -675.271% |
| Organogenesis Holdings Inc. | 119.35 Million USD | -135.944% |
| Universe Pharmaceuticals INC | 5.48 Million USD | -5036.417% |
| ProPhase Labs, Inc. | 21.38 Million USD | -1217.127% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -46216.089% |
| Dynavax Technologies Corporation | 256.91 Million USD | -9.609% |
| Radius Health, Inc. | 365.31 Million USD | 22.915% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -10536.699% |
| Alvotech | 1.07 Billion USD | 73.816% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -42715.825% |
| Alpha Teknova, Inc. | 30.45 Million USD | -824.558% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | -1562.545% |
| SCYNEXIS, Inc. | 15.08 Million USD | -1767.386% |
| Harrow Health, Inc. | 190.5 Million USD | -47.821% |
| Biofrontera Inc. | 5.39 Million USD | -5115.814% |
| DURECT Corporation | 20.74 Million USD | -1257.379% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | -578.117% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | 10.696% |
| OptiNose, Inc. | 131.74 Million USD | -113.741% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -23906.852% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | -184.959% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -1428.079% |
| SIGA Technologies, Inc. | 1.46 Million USD | -19134.979% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | -116.019% |
| Shineco, Inc. | 29.65 Million USD | -849.547% |
| Phibro Animal Health Corporation | 525.45 Million USD | 46.408% |
| Procaps Group S.A. | 285.93 Million USD | 1.515% |
| TherapeuticsMD, Inc. | 8 Million USD | -3417.824% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -470750.936% |
| Viatris Inc. | 18.12 Billion USD | 98.446% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -42715.825% |
| Rockwell Medical, Inc. | 13.43 Million USD | -1995.408% |
| Incannex Healthcare Limited | 373 Thousand USD | -75396.466% |
| Aytu BioPharma, Inc. | 15.12 Million USD | -1761.338% |
| Tilray Brands, Inc. | 387.31 Million USD | 27.294% |
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 58.237% |
| PetIQ, Inc. | 468.3 Million USD | 39.867% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 34.267% |
| Journey Medical Corporation | 17.73 Million USD | -1488.279% |
| Alimera Sciences, Inc. | 67.39 Million USD | -317.813% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | -3302.389% |
| Assertio Holdings, Inc. | 40.91 Million USD | -588.311% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -25789.802% |
| Embecta Corp. | 1.63 Billion USD | 82.813% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -27157.548% |
| Procaps Group, S.A. | 285.93 Million USD | 1.515% |
| PainReform Ltd. | 86 Thousand USD | -327343.976% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | -695.845% |
| Hempacco Co., Inc. | 13.72 Million USD | -1951.818% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 51.949% |
| Alvotech | 1.07 Billion USD | 73.816% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 54.356% |
| Kamada Ltd. | 8.74 Million USD | -3118.679% |
| Currenc Group, Inc. | 31.94 Million USD | -781.558% |
| Evoke Pharma, Inc. | 5 Million USD | -5532.036% |
| Flora Growth Corp. | 3.67 Million USD | -7568.895% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -27157.548% |
| Evolus, Inc. | 126.54 Million USD | -122.529% |
| HUTCHMED (China) Limited | 86.13 Million USD | -226.946% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 54.846% |
| Akanda Corp. | 3.99 Million USD | -6942.174% |